pemetrexed,carboplatin,paclitaxel,vinorelbine,nivolumab,cisplatin,docetaxel,gemcitabine,ipilimumab,pembrolizumab
merck,bms
['cm816', 'kn671', 'pembro']
interesting surgical results from kn671 by pembro/cx group:
18% did not make it to surgery (similar to cm816)
92% r0
18% pcr/30% mpr efr hr 0.58 (mefr not reached vs 17mo) importantly, benefit across all responders (not just cpr/mpr) 
Thoracic, Trauma & Foregut Surgery @CIUSSSNMTL & @McGillU, Chief of Thoracic @ Sacré-Coeur Hospit, Assist Professor @UMontreal, Alum @Stanford